Asystole following regadenoson infusion in stable outpatients

Journal of Nuclear Cardiology

Volumn 21, Issue 5, 2014, Pages 862-868

  Rosenblatt, Jeffrey ^a,b   Mooney, Deirdre ^a   Dunn, Timothy ^b   Cohen, Mylan ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAINE MEDICAL CENTER   (United States)

Author keywords

A2A adenosine receptor agonists; adenosine; pharmacologic stress; vasodilator stress

Indexed keywords

ACETYLSALICYLIC ACID; AMINOPHYLLINE; ASCORBIC ACID; CARVEDILOL; CYANOCOBALAMIN; FENOFIBRATE; FERROUS SULFATE; FINASTERIDE; FISH OIL; FOLIC ACID; FUROSEMIDE; INSULIN; LEVOTHYROXINE; LIRAGLUTIDE; LISINOPRIL; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; REGADENOSON; RETINOL; ROSUVASTATIN; ADENOSINE A2 RECEPTOR AGONIST; PURINE DERIVATIVE; PYRAZOLE DERIVATIVE; VASODILATOR AGENT;

AGED; ANGIOCARDIOGRAPHY; ANTICOAGULATION; ARTICLE; BRADYCARDIA; CARDIOVERSION; CASE REPORT; COLLAPSE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW UP; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART HEMODYNAMICS; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HYPERTENSION; KNEE OSTEOARTHRITIS; MALE; OUTPATIENT; POSITIVE END EXPIRATORY PRESSURE; Q WAVE; RESUSCITATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SINUS BRADYCARDIA; SLEEP DISORDERED BREATHING; ST SEGMENT DEPRESSION; T WAVE; ADVERSE EFFECTS; AMBULATORY CARE; CHEMICALLY INDUCED; COMPLICATION; DIAGNOSTIC USE; INTRAVENOUS DRUG ADMINISTRATION; MYOCARDIAL PERFUSION IMAGING; SCINTISCANNING;

ADENOSINE A2 RECEPTOR AGONISTS; AGED; AMBULATORY CARE; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; HEART ARREST; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MYOCARDIAL PERFUSION IMAGING; PURINES; PYRAZOLES; VASODILATOR AGENTS;

EID: 84907592860     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-014-9898-0     Document Type: Article

References (16)

1. Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 2007;14:645-58.
2. Cerqueira MD, Nguyen P, Staehr P, Underwood SR, Iskandrian AE, ADVANCE-MPI Trial Investigators. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging 2008;1:307-16.
3. Pandit A, Unzek-Freiman S. Complete heart block associated with regadenoson: A real side effect. J Nucl Cardiol 2012;19:1236-9.
4. Grady EC, Barron JT, Wagner RH. Development of asystole requiring cardiac resuscitation after the administration of regadenoson in a patient with pulmonary fibrosis receiving n-acetylcysteine. J Nucl Cardiol 2011;18:521-5.
5. U.S. Food and Drug Administration. Drug Safety Communications: FDA warns of rare but serious risk of heart attack and death with cardiac nuclear stress test drugs Lexiscan (regadenoson) and Adenoscan (adenosine). http://www.fda.gov/downloads/Drugs/DrugSafety/UCM375668. Accessed February 13, 2014.
6. Shah S, Parra D, Rosenstein RS. Acute myocardial infarction during regadenoson myocardial perfusion imaging. Pharmacotherapy 2013;33:90-5.
7. Hsi DH, Marreddy R, Moshiyakhov M, Luft U. Regadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis. J Nucl Cardiol 2013;20:481-4.
8. Mustafa SJ, Morrison RR, Teng B, Pelleg A. Adenosine receptors and the heart: Role in regulation of coronary blood flow and cardiac electrophysiology. Handb Exp Pharmacol 2009;193:161-88.
9. Kang MJ, Park MS, Shin IC, Koh HC. Modification of cardiovascular response of posterior hypothalamic adenosine A(2) receptor stimulation by adenylate cylase, guanylate cyclase and by K(ATP) channel blockade in anesthetized rats. Neurosci Lett 2003;344:57-61.
10. Brinkert M, Reyes E, Walker S, Latus K, Maenhout A, Mizumoto R, et al. Regadenoson in Europe: First-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy. Eur J Nucl Med Mol Imaging 2014;41:511-21.
11. Hove-Madsen L, Prat-Vidal C, Llach-Ciruela F, Casado V, Lluis C, Bayes-Genis A, et al. Adenosine A2A receptors are expressed in human atrial myocytes and modulate spontaneous sarcoplasmic reticulum calcium release. Cardiovasc Res 2006;72:292-302.
12. Marala RB, Mustafa SJ. Immunological characterization of adenosine A2A receptors in human and porcine cardiovascular tissues. J Pharmacol Exp Ther 1998;286:1051-7.
13. Kilpatrick EL, Narayan P, Mentzer RM Jr, Lasley RD. Cardiac myocyte adenosine A2a receptor activation fails to alter cAMP or contractility: Role of receptor localization. Am J Physiol Heart Circ Physiol 2002;282:H1035-40.
14. Gao Z, Li Z, Baker SP, Lasley RD, Meyer S, Elzein E, et al. Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: Inverse relationship between affinity and duration of action of A2A agonists. J Pharmacol Exp Ther 2001;298:209-18.
15. Llach A, Molina CE, Prat-Vidal C, Fernandes J, Casadó V, Ciruela F, et al. Abnormal calcium handling in atrial fibrillation is linked to up-regulation of adenosine A2A receptors. Eur Heart J 2011;32:721-9.
16. Gordi T, Frohna P, Sun HL, Wolff A, Belardinelli L, Lieu H. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers. Clin Pharmacokinet 2006;45:1201-12.